(Q80296428)

PubMed publication ID

16985714

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16985714%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

review article

1 reference

title

Current Clinical Applications of the In-capromab Pendetide Scan (ProstaScint(R) Scan, Cyt-356) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1476063&resulttype=core&format=json

10 May 2020

author name string

M Han

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1476063&resulttype=core&format=json

10 May 2020

A W Partin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1476063&resulttype=core&format=json

10 May 2020

publication date

1 January 2001

1 reference

PubMed publication ID

16985714

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16985714%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1476063&resulttype=core&format=json

10 May 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1476063&resulttype=core&format=json

10 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1476063&resulttype=core&format=json

10 May 2020

page(s)

165-171

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1476063&resulttype=core&format=json

111Indium-capromab pendetide in the evaluation of patients with residual or recurrent prostate cancer after radical prostatectomy. The ProstaScint Study Group

10 May 2020

cites work

1 reference

12 December 2020

Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy

1 reference

12 December 2020

Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients

1 reference

12 December 2020

Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients

1 reference

12 December 2020

Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients.

1 reference

12 December 2020

Radioimmunoscintigraphy of pelvic lymph nodes with 111indium-labeled monoclonal antibody CYT-356

1 reference

12 December 2020

Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature

1 reference

12 December 2020

Radioimmunoscintigraphy with 111indium labeled CYT-356 for the detection of occult prostate cancer recurrence

1 reference

12 December 2020

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

12 December 2020

Lucy Wortham James Basic Research Award. Markers of prostatic carcinoma

1 reference

12 December 2020

Immunoscintigraphy of prostatic cancer: preliminary results with 111In-labeled monoclonal antibody 7E11-C5.3 (CYT-356)

1 reference

12 December 2020

Biochemical characterization and mapping of the 7E11-C5.3 epitope of the prostate-specific membrane antigen

1 reference

12 December 2020

Quantitative analysis of antibody localization in human metastatic colon cancer: a phase I study of monoclonal antibody A33.

1 reference

12 December 2020

Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience

1 reference

12 December 2020

Clinical Applications of Radioimmunoscintigraphy With Prostate-Specific Antibodies for Prostate Cancer

1 reference

12 December 2020

Indium-111-capromab pendetide scans: an important test relevant to clinical decision making

1 reference

12 December 2020

Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate Cancer

1 reference

12 December 2020

Radiolabeled monoclonal antibody indium 111-labeled CYT-356 localizes extraprostatic recurrent carcinoma after prostatectomy

1 reference

12 December 2020

The Incidence and Significance of Detectable Levels of Serum Prostate Specific Antigen After Radical Prostatectomy

1 reference

12 December 2020

Preliminary imaging results using In-111 labeled CYT-356 (Prostascint) in the detection of recurrent prostate cancer

1 reference

12 December 2020

A Phase II Study of [90Y] Yttrium-Capromab Pendetide in the Treatment of Men with Prostate Cancer Recurrence Following Radical Prostatectomy

1 reference

12 December 2020

Radioimmunoscintigraphy of prostate cancer

1 reference

12 December 2020

Monoclonal antibody 7E11.C5 staining of viable LNCaP cells

1 reference

12 December 2020

Two different lymph node metastatic patterns of a prostatic cancer

1 reference

12 December 2020

5-Year Tumor Recurrence Rates After Anatomical Radical Retropubic Prostatectomy For Prostate Cancer

1 reference

12 December 2020

Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results

1 reference

12 December 2020

Prostate cancer abdominal metastases detected with indium-111 capromab pendetide

1 reference

12 December 2020

Can Radical Prostatectomy Alter the Progression of Poorly Differentiated Prostate Cancer?

1 reference

12 December 2020

Immunoscintigraphy with indium-111-capromab pendetide: evaluation before definitive therapy in patients with prostate cancer.

1 reference

12 December 2020

PROSTASCINT scan for staging prostate cancer

1 reference

12 December 2020

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC1476063&resulttype=core&format=json

10 May 2020

PubMed publication ID

16985714

1 reference